Sleep Apnea dev Invicta Medical raises $21m
Sleep apnea device developer Invicta Medical has raised approximately $21 million in a new round of equity financing, according to an SEC filing posted this week. The Palo Alto, Calif.-based company, founded in 2013, has not yet revealed the technology behind its development but claims that its solution to treating obstructive sleep apnea is non-invasive, customizable to meet patient needs and affordable, according to its website. The company has not yet officially stated how it plans to spend funds raised in the round. The round was joined by 6 anonymous investors, with the first sale in the round dated on December 20, 2017, according to the SEC filing. The post Sleep Apnea dev Invicta Medical raises $21m appeared first on MassDevice.
Are menopausal vasomotor symptoms associated with increased risk of obstructive sleep apnea, independent of obesity?Menopause
AbstractStudy objectivesSubjects with obstructive sleep apnea (OSA) have neurocognitive dysfunction. The aim of this study was to estimate the prevalence of symptoms and risk of OSA among university students and the association with academic performance.MethodsA cross-sectional study was conducted at Jordan University of Science and Technology. Students from faculties of engineering, medicine, nursing, pharmacy, and dentistry were asked to participate in this study. The Berlin Sleep Questionnaire was used to report symptoms and risk of OSA. Below average cumulative scores were considered poor academic performance.ResultsA ...
Obstructive sleep apnea (OSA) affects an estimated 20% of the adult surgical population. Veteran patients have many characteristics consistent with OSA, but lack of standardized screening results in decreased detection of patients at risk for OSA.
Medical cannabis and synthetic marijuana extracts should not be used to treat obstructive sleep apnea, the American Academy of Sleep Medicine says in a new position statement.Medscape Medical News
Conclusion The results of the present study suggest that OSAS is associated with OAB syndrome. As a key symptom of OAB, urgency correlates with hypoxia in cases with OSAS. Although the present study did not observe any difference in BWT measurements between the patients and the control group, there was a correlation between BWT measurements and OABSS in patients with OSAS.
Intermittent hypoxia (IH), a typical character of obstructive sleep apnea (OSA), is related to atherogenesis. However, the role of IH on atherosclerosis (AS) progression and the mechanisms involved remains poo...
AbstractObstructive sleep apnea (OSA) might influence disease severity in acute pulmonary embolism (PE). 253 survivors of acute PE were evaluated for sleep-disordered breathing by portable monitoring and nocturnal polysomnography. PE patients with an apnea-hypopnoea index (AHI) ≥ 15/h were significantly older (p
CONCLUSIONS Our study shows that sustained hypoxia promotes autophagy in GG MDSCs, and the HIF-1a/BNIP3 signal pathway was involved in this process. PMID: 29652869 [PubMed - in process]
Abstract Background: Rapid eye movement (REM) sleep behavior disorder (RBD) and obstructive sleep apnea (OSA) are the most common sleep disorders in Parkinson's disease (PD). The aim of this study was to identify whether RBD could alleviate OSA severity in PD patients and its effect on cognitive impairment. Methods: From February 2014 to May 2017, we recruited 174 PD patients from the Second Affiliated Hospital of Soochow University, all of whom underwent polysomnography (PSG). We collected clinical data, PSG results, and compared information between patients with and without RBD or OSA by analysis of covaria...